Wang Yan, Yang Chao, Wen Jun, Ju Lingling, Ren Zhengyun, Zhang Tongtong, Liu Yanjun
Center of Gastrointestinal and Minimally Invasive Surgery, Department of General Surgery, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
Medical Research Center, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, Chengdu, China.
Front Endocrinol (Lausanne). 2024 Feb 26;15:1334342. doi: 10.3389/fendo.2024.1334342. eCollection 2024.
Early-onset obesity is a rising health concern influenced by heredity. However, many monogenic obesity variants (MOVs) remain to be discovered due to differences in ethnicity and culture. Additionally, patients with known MOVs have shown limited weight loss after bariatric surgery, suggesting it can be used as a screening tool for new candidates. In this study, we performed whole-exome sequencing (WES) combined with postoperative data to detect candidate MOVs in a cohort of 62 early-onset obesity and 9 late-onset obesity patients. Our findings demonstrated that patients with early-onset obesity preferred a higher BMI and waist circumference (WC). We confirmed the efficacy of the method by identifying a mutation in known monogenic obesity gene, , which resulted in less weight loss after surgery. 5 genes were selected for further verification, and a frameshift variant in gene: NM_001270486.1, c.1614dup, (p. Gly539Argfs*3) was identified as a novel candidate MOV. This mutation influenced the improvement of metabolism after bariatric surgery. In conclusion, our data confirm the efficacy of WES combined with postoperative data in detecting novel candidate MOVs and c.1614dup (CAMKK2) might be a promising MOV, which needs further confirmation. This study enriches the human monogenic obesity mutation database and provides a scientific basis for clinically accurate diagnosis and treatment.
早发性肥胖是一个受遗传影响且日益引起健康关注的问题。然而,由于种族和文化差异,许多单基因肥胖变异体(MOVs)仍有待发现。此外,已知携带MOVs的患者在减肥手术后体重减轻有限,这表明减肥手术可作为新候选者的筛查工具。在本研究中,我们进行了全外显子组测序(WES)并结合术后数据,以在62例早发性肥胖患者和9例晚发性肥胖患者队列中检测候选MOVs。我们的研究结果表明,早发性肥胖患者的体重指数(BMI)和腰围(WC)较高。我们通过在已知的单基因肥胖基因中鉴定出一个突变,证实了该方法的有效性,该突变导致术后体重减轻较少。选择了5个基因进行进一步验证,并在基因NM_001270486.1中鉴定出一个移码变异:c.1614dup,(p.Gly539Argfs*3),作为一个新的候选MOV。该突变影响了减肥手术后代谢的改善。总之,我们的数据证实了WES结合术后数据在检测新的候选MOVs方面的有效性,并且c.1614dup(CAMKK₂)可能是一个有前景的MOV,但需要进一步证实。本研究丰富了人类单基因肥胖突变数据库,并为临床准确诊断和治疗提供了科学依据。